newsfilter
← Latest News
Business Wire·

Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced the appointments of Thomas Lynch, M.D., and Eric Rubin, M.D., to the Company's board of directors. "Tom and Eric